Jiangsu Huifeng Bio Agriculture Co., Ltd. (SHE:002496)
China · Delayed Price · Currency is CNY 1.820
+0.050 (2.82%)
Feb 6, 2026, 3:04 PM CST
SHE:002496 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 309.21 | 243.65 | 215.57 | 252.73 | 1,049 | 1,663 |
Other Revenue | 36.36 | 36.36 | 15.54 | 14.81 | 46.74 | 26.39 |
| 345.58 | 280.01 | 231.11 | 267.54 | 1,095 | 1,689 | |
Revenue Growth (YoY) | 54.45% | 21.16% | -13.61% | -75.58% | -35.14% | 37.72% |
Cost of Revenue | 337.58 | 253.57 | 174.09 | 215.43 | 952.63 | 1,256 |
Gross Profit | 8 | 26.44 | 57.03 | 52.1 | 142.86 | 432.8 |
Selling, General & Admin | 93.13 | 107.89 | 133.16 | 184.87 | 368.75 | 479.62 |
Research & Development | 1.31 | 1.53 | 2.11 | 2.11 | 28.87 | 35.22 |
Other Operating Expenses | 7.62 | 5.18 | 5.34 | 6.71 | 12.25 | 12.19 |
Operating Expenses | 80.29 | 117.76 | 228.1 | 231.28 | 470.91 | 600.58 |
Operating Income | -72.3 | -91.32 | -171.07 | -179.17 | -328.06 | -167.78 |
Interest Expense | -17.23 | -17.66 | -18.21 | -18.33 | -17.94 | -24.87 |
Interest & Investment Income | 53.84 | 4.68 | 0.96 | 1.69 | 686.61 | 126.43 |
Currency Exchange Gain (Loss) | -0.51 | -0.51 | -0.14 | -2.36 | -1.36 | -9.02 |
Other Non Operating Income (Expenses) | -9.59 | -1.77 | -57.66 | -80.46 | -23.82 | -153.37 |
EBT Excluding Unusual Items | -45.79 | -106.58 | -246.12 | -278.63 | 315.44 | -228.59 |
Gain (Loss) on Sale of Investments | -190.73 | -191.83 | -205.07 | -68.8 | 62.21 | 99.67 |
Gain (Loss) on Sale of Assets | 11.94 | 77.54 | 0.91 | 18.83 | 1.47 | 1.89 |
Asset Writedown | -45.17 | -44.73 | -10.46 | -15.13 | -136.43 | -274.06 |
Other Unusual Items | 126.66 | 126.07 | 3.84 | -8.17 | 14.42 | 17.85 |
Pretax Income | -143.09 | -139.53 | -456.9 | -351.9 | 257.1 | -383.24 |
Income Tax Expense | 19.37 | 15.94 | 12.28 | 21.6 | 54.05 | -35.32 |
Earnings From Continuing Operations | -162.46 | -155.47 | -469.18 | -373.5 | 203.05 | -347.92 |
Minority Interest in Earnings | 2.84 | 0.37 | 1.85 | -81.44 | 104.69 | 62.94 |
Net Income | -159.63 | -155.09 | -467.33 | -454.95 | 307.74 | -284.97 |
Net Income to Common | -159.63 | -155.09 | -467.33 | -454.95 | 307.74 | -284.97 |
Shares Outstanding (Basic) | 1,617 | 1,551 | 1,508 | 1,516 | 1,539 | 1,500 |
Shares Outstanding (Diluted) | 1,617 | 1,551 | 1,508 | 1,516 | 1,539 | 1,500 |
Shares Change (YoY) | 10.50% | 2.88% | -0.59% | -1.44% | 2.59% | -1.78% |
EPS (Basic) | -0.10 | -0.10 | -0.31 | -0.30 | 0.20 | -0.19 |
EPS (Diluted) | -0.10 | -0.10 | -0.31 | -0.30 | 0.20 | -0.19 |
Free Cash Flow | -37.67 | -60.04 | -58.48 | -99.26 | -69.53 | 58.99 |
Free Cash Flow Per Share | -0.02 | -0.04 | -0.04 | -0.07 | -0.04 | 0.04 |
Gross Margin | 2.31% | 9.44% | 24.67% | 19.48% | 13.04% | 25.62% |
Operating Margin | -20.92% | -32.61% | -74.02% | -66.97% | -29.95% | -9.93% |
Profit Margin | -46.19% | -55.39% | -202.21% | -170.05% | 28.09% | -16.87% |
Free Cash Flow Margin | -10.90% | -21.44% | -25.30% | -37.10% | -6.35% | 3.49% |
EBITDA | -40.89 | -55.09 | -128.41 | -134.22 | -190.11 | 95.63 |
EBITDA Margin | -11.83% | -19.67% | -55.56% | -50.17% | -17.35% | 5.66% |
D&A For EBITDA | 31.41 | 36.23 | 42.66 | 44.95 | 137.94 | 263.4 |
EBIT | -72.3 | -91.32 | -171.07 | -179.17 | -328.06 | -167.78 |
EBIT Margin | -20.92% | -32.61% | -74.02% | -66.97% | -29.95% | -9.93% |
Effective Tax Rate | - | - | - | - | 21.02% | - |
Revenue as Reported | 345.58 | 280.01 | 231.11 | 267.54 | 1,095 | 1,689 |
Advertising Expenses | - | 5.02 | 5.91 | 3.68 | 3.65 | 4.41 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.